| Home | E-Submission | Sitemap | Editorial Office |  
ORIGINAL ARTICLE 2024 January 18
Phase 1/2a Study of Rivoceranib, a Selective VEGFR-2 Angiogenesis Inhibitor, in Patients with Advanced Solid Tumors
Purpose This study aimed to report the results from an early-phase study of rivoceranib, an oral tyrosine kinase inhibitor highly selective for vascular endothelial growth factor receptor 2, in patients with advanced solid tumors. Materials and Methods In this open-label, singl...
Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in Non–Small Cell Lung Cancer
Purpose There have been needs to improve the sensitivity of liquid biopsy. This report aims to report the analytical and clinical validation of a next-generation sequencing (NGS)–based circulating tumor DNA (ctDNA) assay. Materials and Methods Analytical validation was conduct...
ORIGINAL ARTICLE 2024 January 30
Comparison of Clinicopathogenomic Features and Treatment Outcomes of EGFR and HER2 Exon 20 Insertion Mutations in Non–Small Cell Lung Cancer: Single-Institution Experience
Purpose Exon 20 insertion mutations (E20ins) in epidermal growth factor receptor (EGFR) or human epidermal growth factor receptor 2 (HER2) in non–small cell lung cancer (NSCLC) patients has become more important with emergence of novel agents targeting E20ins. Materials and Me...
Current Issue
Volume 56(3); Jul 2024
Volume 56(2); April 2024
Volume 56(1); January 2024
RSS feed
699 Editor’s Note on Recent Journal Impact Factor of Cancer Research and Treatment
Yong Chan Ahn
Cancer Res Treat. 2024;56(3):699-699.   Published online July 9, 2024    DOI: https://doi.org/10.4143/crt.2024.619
Review Article
700 HER2-Low Breast Cancer: Now and in the Future
Sora Kang, Sung-Bae Kim
Cancer Res Treat. 2024;56(3):700-720.   Published online January 30, 2024    DOI: https://doi.org/10.4143/crt.2023.1138
Special Article
721 Clinical Practice Recommendations for the Use of Next-Generation Sequencing in Patients with Solid Cancer: A Joint Report from KSMO and KSP
Miso Kim, Hyo Sup Shim, Sheehyun Kim, In Hee Lee, Jihun Kim, Shinkyo Yoon, Hyung-Don Kim, Inkeun Park, Jae Ho Jeong, Changhoon Yoo, Jaekyung Cheon, In-Ho Kim, Jieun Lee, Sook Hee Hong, Sehhoon Park, Hyun Ae Jung, Jin Won Kim, Han Jo Kim, Yongjun Cha, Sun Min Lim, Han Sang Kim, Choong-kun Lee, Jee Hung Kim, Sang Hoon Chun, Jina Yun, So Yeon Park, Hye Seung Lee, Yong Mee Cho, Soo Jeong Nam, Kiyong Na, Sun Och Yoon, Ahwon Lee, Kee-Taek Jang, Hongseok Yun, Sungyoung Lee, Jee Hyun Kim, Wan-Seop Kim
Cancer Res Treat. 2024;56(3):721-742.   Published online November 29, 2023    DOI: https://doi.org/10.4143/crt.2023.1043
Original Articles
743 Phase 1/2a Study of Rivoceranib, a Selective VEGFR-2 Angiogenesis Inhibitor, in Patients with Advanced Solid Tumors
Yoon-Koo Kang, Min-Hee Ryu, Yong Sang Hong, Chang-Min Choi, Tae Won Kim, Baek-Yeol Ryoo, Jeong Eun Kim, John R. Weis, Rachel Kingsford, Cheol Hee Park, Seong Jang, Arlo McGinn, Theresa L. Werner, Sunil Sharma
Cancer Res Treat. 2024;56(3):743-750.   Published online January 18, 2024    DOI: https://doi.org/10.4143/crt.2023.980
Lung and Thoracic cancer
751 Association of Immune-Related Adverse Events and the Efficacy of Anti–PD-(L)1 Monotherapy in Non–Small Cell Lung Cancer: Adjusting for Immortal-Time Bias
Ying Yu, Ning Chen, Sizhe Yu, Wanji Shen, Wanchen Zhai, Hui Li, Yun Fan
Cancer Res Treat. 2024;56(3):751-764.   Published online January 2, 2024    DOI: https://doi.org/10.4143/crt.2023.1118
765 Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in Non–Small Cell Lung Cancer
Hanbaek Yi, Jeonghwan Youk, Yoojoo Lim, Hanseong Roh, Dongsoo Kyung, Hwang-Phill Kim, Duhee Bang, Bhumsuk Keam, Tae-Min Kim, Miso Kim, Dong-Wan Kim, Tae-You Kim
Cancer Res Treat. 2024;56(3):765-773.   Published online January 8, 2024    DOI: https://doi.org/10.4143/crt.2023.1294
                        Supplementary         Crossref 1
774 Comparison of Clinicopathogenomic Features and Treatment Outcomes of EGFR and HER2 Exon 20 Insertion Mutations in Non–Small Cell Lung Cancer: Single-Institution Experience
So Heun Lee, Hyehyun Jeong, Deok Hoon Kim, Se Jin Jang, Sang-We Kim, Shinkyo Yoon, Dae Ho Lee
Cancer Res Treat. 2024;56(3):774-784.   Published online January 30, 2024    DOI: https://doi.org/10.4143/crt.2023.1177
785 Contribution of Enhanced Locoregional Control to Improved Overall Survival with Consolidative Durvalumab after Concurrent Chemoradiotherapy in Locally Advanced Non–Small Cell Lung Cancer: Insights from Real-World Data
Jeong Yun Jang, Si Yeol Song, Young Seob Shin, Ha Un Kim, Eun Kyung Choi, Sang-We Kim, Jae Cheol Lee, Dae Ho Lee, Chang-Min Choi, Shinkyo Yoon, Su Ssan Kim
Cancer Res Treat. 2024;56(3):785-794.   Published online January 16, 2024    DOI: https://doi.org/10.4143/crt.2023.1014
                        Supplementary         Crossref 1
Breast cancer
795 Trastuzumab Biosimilar (HLX02), Pertuzumab Plus Chemotherapy in Patients with HER2-Positive Metastatic Breast Cancer after Progression of Trastuzumab: A Prospective, Phase II Study
Ruyan Zhang, Xiaoran Liu, Guohong Song, Yan Zhang, Huiping Li
Cancer Res Treat. 2024;56(3):795-801.   Published online December 20, 2023    DOI: https://doi.org/10.4143/crt.2023.1151
802 Implementation of BRCA Test among Young Breast Cancer Patients in South Korea: A Nationwide Cohort Study
Yung-Huyn Hwang, Tae-Kyung Yoo, Sae Byul Lee, Jisun Kim, Beom Seok Ko, Hee Jeong Kim, Jong Won Lee, Byung Ho Son, Il Yong Chung
Cancer Res Treat. 2024;56(3):802-808.   Published online February 19, 2024    DOI: https://doi.org/10.4143/crt.2023.1186
Gastrointestinal cancer
809 The Clinical Efficacy of Colorectal Cancer Patients with Pulmonary Oligometastases by Sterotactic Body Ablative Radiotherapy: A Meta-Analysis
Jae-Uk Jeong, Chai Hong Rim, Gyu Sang Yoo, Won Kyung Cho, Eui Kyu Chie, Yong Chan Ahn, Jong Hoon Lee, on behalf of Korean Oligometastasis Working Group, Korean Cancer Association
Cancer Res Treat. 2024;56(3):809-824.   Published online December 14, 2023    DOI: https://doi.org/10.4143/crt.2023.920
825 The Persistence of Hypertriglyceridemia and the Risk of Early Onset Colorectal Cancer According to Tumor Subsites: A Nationwide Population-Based Study
Young Hoon Chang, Cheol Min Shin, Kyungdo Han, Jin Hyung Jung, Eun Hyo Jin, Joo Hyun Lim, Seung Joo Kang, Yoon Jin Choi, Hyuk Yoon, Young Soo Park, Nayoung Kim, Dong Ho Lee
Cancer Res Treat. 2024;56(3):825-837.   Published online December 20, 2023    DOI: https://doi.org/10.4143/crt.2023.753
838 Combined High-Dose Radiotherapy with Sequential Gemcitabine-Cisplatin Based Chemotherapy Increase the Resectability and Survival in Locally Advanced Unresectable Intrahepatic Cholangiocarcinoma: A Multi-institutional Cohort Study
Jung Ho Im, Jeong Il Yu, Tae Hyun Kim, Tae Gyu Kim, Jun Won Kim, Jinsil Seong
Cancer Res Treat. 2024;56(3):838-846.   Published online January 2, 2024    DOI: https://doi.org/10.4143/crt.2023.886
847 Global Expanded Access Program for Pemigatinib in Patients with Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma and Fibroblast Growth Factor Receptor Gene Alterations
Anouk Lindley, Gerald Prager, Michael Bitzer, Timothy C. Burn, Christine F. Lihou, Elisabeth Croft
Cancer Res Treat. 2024;56(3):847-855.   Published online February 7, 2024    DOI: https://doi.org/10.4143/crt.2023.1197
Genitourinary cancer
856 Invasiveness of Upper Tract Urothelial Carcinoma: Clinical Significance and Integrative Diagnostic Strategy
Bokyung Ahn, Doeun Kim, Kye Jin Park, Ja-Min Park, Sun Young Yoon, Bumsik Hong, Yong Mee Cho, Deokhoon Kim
Cancer Res Treat. 2024;56(3):856-870.   Published online December 18, 2023    DOI: https://doi.org/10.4143/crt.2023.1150
                        Supplementary         Crossref 1
871 Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Real-World, Retrospective Study
Junho Lee, Sung Hee Lim, Jae Hoon Chung, Wan Song, Hyun Hwan Sung, Byong Chang Jeong, Se Hoon Park
Cancer Res Treat. 2024;56(3):871-876.   Published online January 16, 2024    DOI: https://doi.org/10.4143/crt.2023.1226
877 Single Early Intravesical Instillation of Epirubicin for Preventing Bladder Recurrence after Nephroureterectomy in Upper Urinary Tract Urothelial Carcinoma
Jong Hoon Lee, Chung Un Lee, Jae Hoon Chung, Wan Song, Minyong Kang, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Hwan Sung
Cancer Res Treat. 2024;56(3):877-884.   Published online January 17, 2024    DOI: https://doi.org/10.4143/crt.2023.1219
885 Bilateral Seminal Vesicle Invasion as a Strong Prognostic Indicator in T3b Prostate Cancer Patients Following Radical Prostatectomy: A Comprehensive, Multicenter, Long-term Follow-up Study
Jungyo Suh, In Gab Jeong, Hwang Gyun Jeon, Chang Wook Jeong, Sangchul Lee, Seong Soo Jeon, Seok-Soo Byun, Cheol Kwak, Hanjong Ahn
Cancer Res Treat. 2024;56(3):885-892.   Published online January 5, 2024    DOI: https://doi.org/10.4143/crt.2023.1264
893 Neoadjuvant Cisplatin-Based Chemotherapy Followed by Selective Bladder Preservation Chemoradiotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder: Post Hoc Analysis of Two Prospective Studies
Sung Wook Cho, Sung Hee Lim, Ghee Young Kwon, Chan Kyo Kim, Won Park, Hongryull Pyo, Jae Hoon Chung, Wan Song, Hyun Hwan Sung, Byong Chang Jeong, Se Hoon Park
Cancer Res Treat. 2024;56(3):893-897.   Published online February 15, 2024    DOI: https://doi.org/10.4143/crt.2024.015
Gynecologic cancer
898 Predicted Cervical Cancer Prevention: Impact of National HPV Vaccination Program on Young Women in South Korea
Kyeongmin Kwak, Seung-sik Hwang
Cancer Res Treat. 2024;56(3):898-908.   Published online January 15, 2024    DOI: https://doi.org/10.4143/crt.2023.981
Pediatric cancer
909 The Role of Early and Delayed Surgery for Infants with Congenital Brain Tumors
Jong Seok Lee, Ji Yeoun Lee, Kyung Hyun Kim, Sung-Hye Park, Eun Jung Koh, Seung-Ki Kim, Ji Hoon Phi
Cancer Res Treat. 2024;56(3):909-919.   Published online December 28, 2023    DOI: https://doi.org/10.4143/crt.2023.1174
Hematologic malignancy
920 Feasibility of Circulating Tumor DNA Analysis in Patients with Follicular Lymphoma
Sang Eun Yoon, Seung-Ho Shin, Dae Keun Nam, Junhun Cho, Won Seog Kim, Seok Jin Kim
Cancer Res Treat. 2024;56(3):920-935.   Published online January 16, 2024    DOI: https://doi.org/10.4143/crt.2023.869
936 Secondary Malignancies in Multiple Myeloma in Korean Patients: A Nationwide Population-Based Study
Boyoung Park, Eunyoung Lee, Junghyun Yoon, YoungJu Park, Hyeon-Seok Eom
Cancer Res Treat. 2024;56(3):936-944.   Published online December 18, 2023    DOI: https://doi.org/10.4143/crt.2023.843
945 CD19-Specific CAR-T Cell Treatment of 115 Children and Young Adults with Acute B Lymphoblastic Leukemia: Long-term Follow-up
Yu Wang, Yu-juan Xue, Ying-xi Zuo, Yue-ping Jia, Ai-dong Lu, Hui-min Zeng, Le-ping Zhang
Cancer Res Treat. 2024;56(3):945-955.   Published online February 13, 2024    DOI: https://doi.org/10.4143/crt.2023.1205
956 Nation-Wide Retrospective Analysis of Allogeneic Stem Cell Transplantation in Patients with Multiple Myeloma: A Study from Korean Multiple Myeloma Working Party (KMM1913)
Ho-Jin Shin, Do-Young Kim, Kihyun Kim, Chang-Ki Min, Je-Jung Lee, Yeung-Chul Mun, Won-Sik Lee, Sung-Nam Lim, Jin Seok Kim, Joon Ho Moon, Da Jung Kim, Soo-Mee Bang, Jong-Ho Won, Jae-Cheol Jo, Young Il Koh
Cancer Res Treat. 2024;56(3):956-966.   Published online March 4, 2024    DOI: https://doi.org/10.4143/crt.2024.074
Case Report
967 Molecular and Treatment Characteristics of SMARCB1 or SMARCA4-Deficient Undifferentiated Tumor: Retrospective Case Series
Hyeon Gyu Kang, Jiwon Koh, Tae Min Kim, Doo Hee Han, Tae-Bin Won, Dong-Wan Kim, Dong-Young Kim, Bhumsuk Keam
Cancer Res Treat. 2024;56(3):967-971.   Published online February 13, 2024    DOI: https://doi.org/10.4143/crt.2023.1308
972 Bridging the Gap between Trial Adverse Events and Real-World Data
Sang Hyuk Kim, Hyun Lee, Dong Won Park
Cancer Res Treat. 2024;56(3):972-973.   Published online January 10, 2024    DOI: https://doi.org/10.4143/crt.2024.019
Korean Cancer Association
EndNote Output Style
Email Alert
Journal Impact Factor 4.1
SCImago Journal & Country Rank
PubMed Central
Similarity Check
Crossref Cited-by Linking
Funder Registry
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI